Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.930
+0.040 (1.03%)
At close: Aug 24, 2026, 4:00 PM EDT
4.000
+0.070 (1.78%)
After-hours: Aug 24, 2026, 7:21 PM EDT
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $18.11 million as of August 24, 2026. Its market cap has increased by 127.01% in one year.
Market Cap
18.11M
Enterprise Value
16.72M
1-Year Change
127.01%
Ranking
Category
Stock Price
$3.93
ChartMarket Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $18.11M, a decrease of -90.63%. That is a compound annual growth rate of -27.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 18.11M | 274.58% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 20.03M |
| CalciMedica | 19.00M |
| NewcelX | 18.63M |
| Palatin Technologies | 18.50M |
| Tempest Therapeutics | 17.58M |
| Lexaria Bioscience | 17.42M |
| Lipocine | 16.98M |
| Pasithea Therapeutics | 16.87M |